Anna E. Barón

17.2k total citations · 2 hit papers
231 papers, 12.8k citations indexed

About

Anna E. Barón is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anna E. Barón has authored 231 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 50 papers in Pulmonary and Respiratory Medicine and 38 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anna E. Barón's work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (14 papers) and Cardiac, Anesthesia and Surgical Outcomes (13 papers). Anna E. Barón is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (14 papers) and Cardiac, Anesthesia and Surgical Outcomes (13 papers). Anna E. Barón collaborates with scholars based in United States, Italy and France. Anna E. Barón's co-authors include Wilbur A. Franklin, Paul A. Bunn, Chan Zeng, Marileila Varella‐Garcia, Robert Veve, Fred R. Hirsch, Roy M. Bremnes, Silvia Franceschi, Carlo La Vecchia and Michael V. Di Maria and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Circulation.

In The Last Decade

Anna E. Barón

225 papers receiving 12.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis

2003 1.2k citations Fred R. Hirsch, Marileila Varella‐Garcia et al. profile →
Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy.

1990 455 citations Anna E. Barón et al. PubMed profile →

Peers

Countries citing papers authored by Anna E. Barón

Since Specialization

Citations

This map shows the geographic impact of Anna E. Barón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna E. Barón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna E. Barón more than expected).

Fields of papers citing papers by Anna E. Barón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna E. Barón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna E. Barón. The network helps show where Anna E. Barón may publish in the future.

Co-authorship network of co-authors of Anna E. Barón

This figure shows the co-authorship network connecting the top 25 collaborators of Anna E. Barón. A scholar is included among the top collaborators of Anna E. Barón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna E. Barón. Anna E. Barón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Avoidable general anesthesia for nonobstetric surgery during pregnancy: a retrospective cohort pilot study (2011–2020) 2024 ·International Journal of Obstetric Anesthesia ·(unknown), Anna E. Barón, (unknown), Audrey Chagnot, A. Alvès, R. Fauvet, Sondos Albadri, (unknown), L. J. Salomon, (unknown), Gilles Orliaguet, Jean‐Luc Hanouz, (unknown), H. Keïta	0
2	Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program 2023 ·Journal of the American Heart Association ·Rushi V. Parikh, (unknown), Anna E. Barón, Gary K. Grunwald, Mary E. Plomondon, (unknown), Robert W. Yeh, Hani Jneid, Rajesh V. Swaminathan, Stephen W. Waldo, Alexander Monto, Eric A. Secemsky, Priscilla Y. Hsue	4
3	The Intervention Probability Curve: Modeling the Practical Application of Threshold-Guided Decision-Making, Evaluated in Lung, Prostate, and Ovarian Cancers 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Michael N. Kammer, (unknown), Stephen A. Deppen, Eric L. Grogan, Alexander Kaizer, Anna E. Barón, Fabien Maldonado	2
4	Power for balanced linear mixed models with complex missing data processes 2021 ·Communication in Statistics- Theory and Methods ·Kevin Josey, Brandy M. Ringham, Anna E. Barón, Margaret Schenkman, Katherine A. Sauder, Keith E. Muller, Dana Dabelea, Deborah H. Glueck	1
5	Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial to improve quality of life: a study protocol for a randomized clinical trial 2019 ·Trials ·Bridget A. Graney, David H. Au, Anna E. Barón, Andrew Cheng, Sara Combs, Thomas J. Glorioso, (unknown), (unknown), Borsika A. Rabin, Debra P. Ritzwoller, (unknown), Carolyn Turvey, Carolyn H. Welsh, David B. Bekelman	18
6	The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program 2018 ·Clinical Cardiology ·(unknown), Maggie A. Stanislawski, Anna E. Barón, Thomas M. Maddox, Steven M. Bradley, Mladen I. Vidovich	6
7	Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program 2016 ·Circulation ·Bradley A. Maron, Edward Hess, Thomas M. Maddox, Alexander R. Opotowsky, Ryan J. Tedford, Tim Lahm, Karen E. Joynt, Daniel J. Kass, Thomas Stephens, Maggie A. Stanislawski, Erik R. Swenson, Ronald H. Goldstein, Jane A. Leopold, Roham T. Zamanian, Jean Elwing, Mary E. Plomondon, Gary K. Grunwald, Anna E. Barón, John S. Rumsfeld, Gaurav Choudhary	239
8	Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma 2015 ·Cancer Prevention Research ·Daniel T. Merrick, Dexiang Gao, York E. Miller, Robert L. Keith, Anna E. Barón, William J. Feser, Timothy C. Kennedy, Patrick J. Blatchford, (unknown), Fred R. Hirsch, Lynn E. Heasley, Paul A. Bunn, Wilbur A. Franklin	24
9	Interactions between Ultraviolet Light and MC1R and OCA2 Variants Are Determinants of Childhood Nevus and Freckle Phenotypes 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Anna E. Barón, Nancy L. Asdigian, Victoria González, (unknown), Tamara Terzian, (unknown), Enrique C. Torchia, Marianne Berwick, Robert P. Dellavalle, Joseph G. Morelli, Stefan T. Mokrohisky, Lori A. Crane, Neil F. Box	24
10	Neuropilin-2 Is Upregulated in Lung Cancer Cells during TGF-β1–Induced Epithelial–Mesenchymal Transition 2013 ·Cancer Research ·Patrick Nasarre, Robert M. Gemmill, Vincent Potiron, Joëlle Roche, Xian Lu, Anna E. Barón, Christopher Korch, Elizabeth Garrett‐Mayer, Alessandro Laganà, Philip H. Howe, Harry A. Drabkin	55
11	Endobronchial miRNAs as Biomarkers in Lung Cancer Chemoprevention 2012 ·Cancer Prevention Research ·Céline Mascaux, William J. Feser, (unknown), Anna E. Barón, Christopher D. Coldren, Daniel T. Merrick, Timothy C. Kennedy, (unknown), (unknown), Wilbur A. Franklin, John D. Minna, Paul A. Bunn, York E. Miller, Robert L. Keith, Fred R. Hirsch	12
12	Defining a Gene Promoter Methylation Signature in Sputum for Lung Cancer Risk Assessment 2012 ·Clinical Cancer Research ·Shuguang Leng, Kieu Do, Christin M. Yingling, Maria A. Picchi, Holly J. Wolf, Timothy C. Kennedy, William J. Feser, Anna E. Barón, Wilbur A. Franklin, Malcolm V. Brock, James G. Herman, Stephen B. Baylin, Tim Byers, Christine A. Stidley, Steven A. Belinsky	78
13	Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma 2012 ·Clinical Cancer Research ·Stephen P. Malkoski, Sarah M. Haeger, Timothy G. Cleaver, Karen J. Rodriguez, Howard Li, Shi‐Long Lu, William J. Feser, Anna E. Barón, Daniel T. Merrick, Jessyka G. Lighthall, Hideaki Ijichi, Wilbur A. Franklin, Xiao‐Jing Wang	52
14	The Detection of Chromosomal Aneusomy by Fluorescence In situ Hybridization in Sputum Predicts Lung Cancer Incidence 2010 ·Cancer Prevention Research ·Marileila Varella‐Garcia, (unknown), Holly J. Wolf, William J. Feser, Chan Zeng, (unknown), Xiang Yin, Fred R. Hirsch, Timothy C. Kennedy, Robert L. Keith, Anna E. Barón, Steven A. Belinsky, York E. Miller, Tim Byers, Wilbur A. Franklin	38
15	The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling 2009 ·Journal of Clinical Investigation ·Douglas S. Micalizzi, Kimberly Christensen, Paul Jedlicka, Ricardo D. Coletta, Anna E. Barón, J. Chuck Harrell, Kathryn B. Horwitz, Dean Billheimer, Karen A. Heichman, Alana L. Welm, William P. Schiemann, Heide L. Ford	196
16	Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer 2004 ·Clinical Cancer Research ·Yago Nieto, James J. Vredenburgh, Elizabeth J. Shpall, Scott I. Bearman, Peter A. McSweeney, Nelson J. Chao, David A. Rizzieri, Christina Gasparetto, (unknown), Anna E. Barón, Roy B. Jones	12
17	Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support 2004 ·Biology of Blood and Marrow Transplantation ·Yago Nieto, Wilbur A. Franklin, Roy B. Jones, (unknown), (unknown), Anna E. Barón, Elizabeth J. Shpall	17
18	Initiating contraception in sexually transmitted disease clinic setting: a randomized trial 2003 ·American Journal of Obstetrics and Gynecology ·Judith C. Shlay, (unknown), Mark P. Foster, Moises Maravi, Anna E. Barón, John M. Douglas	22
19	Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. 2001 ·PubMed ·Paul A. Bunn, B. Helfrich, (unknown), Wilbur A. Franklin, Marileila Varella‐Garcia, Fred R. Hirsch, Anna E. Barón, Chan Zeng, Daniel C. Chan	131
20	Usefulness of Human Immunodeficiency Virus Post-Test Counseling by Telephone for Low-Risk Clients of an Urban Sexually Transmitted Diseases Clinic 1996 ·Sexually Transmitted Diseases ·(unknown), Franklyn N. Judson, Anna E. Barón, (unknown), William M. Marine, John M. Douglas	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact